Author: United States. Congress. House. Committee on Energy and CommercePublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 88
Book Description
Medicare Modernization and Prescription Drug Act of 2002 (Title I: Medicare Prescription Drug Benefit)
Author: United States. Congress. House. Committee on Energy and CommercePublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 88
Book Description
Medicare Modernization and Prescription Drug Act of 2002
Author: United States. Congress. House. Committee on Ways and MeansPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 436
Book Description
Competition and the Cost of Medicare's Prescription Drug Program
Author: Anna CookPublisher:
ISBN: 9781457856631
Category :
Languages : en
Pages : 48
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Medicare Primer
Author: Patricia A. DavisPublisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
This report provides a general overview of the Medicare program including descriptions of the program's history, eligibility criteria, covered services, provider payment systems, and program administration and financing.
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Author: United States. CongressPublisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 850
Book Description
Providing for consideration of H.R. 4954, Medicare Modernization and Prescription Drug Act of 2002
Author: United States. Congress. House. Committee on RulesPublisher:
ISBN:
Category : Drugs
Languages : en
Pages : 168
Book Description
United States Congressional Serial Set, Serial No. 14783, House Reports Nos. 535-571
Author: Publisher: Government Printing Office
ISBN:
Category :
Languages : en
Pages : 1190
Book Description
The Serial Set contains the House and Senate Documents and the House and Senate Reports. This volume includes House Reports from 107th Congress, 2nd Session, 2002.
Schedule of Serial Set Volumes
Author: Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 232
Book Description
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
Author: United States. CongressPublisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 850
Book Description